CH505855A - Verfahren zur Herstellung von 4-Oxa-androstanen - Google Patents

Verfahren zur Herstellung von 4-Oxa-androstanen

Info

Publication number
CH505855A
CH505855A CH1567068A CH1567068A CH505855A CH 505855 A CH505855 A CH 505855A CH 1567068 A CH1567068 A CH 1567068A CH 1567068 A CH1567068 A CH 1567068A CH 505855 A CH505855 A CH 505855A
Authority
CH
Switzerland
Prior art keywords
androstanes
oxa
preparation
Prior art date
Application number
CH1567068A
Other languages
German (de)
English (en)
Inventor
Radoje Uskokovic Milan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to CH163071A priority Critical patent/CH508661A/de
Priority to CH162871A priority patent/CH505147A/de
Priority to CH162971A priority patent/CH505148A/de
Publication of CH505855A publication Critical patent/CH505855A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • G—PHYSICS
    • G11—INFORMATION STORAGE
    • G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
    • G11B33/00—Constructional parts, details or accessories not provided for in the other groups of this subclass
    • G11B33/02—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon
    • G11B33/04—Cabinets; Cases; Stands; Disposition of apparatus therein or thereon modified to store record carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1567068A 1967-11-03 1968-10-21 Verfahren zur Herstellung von 4-Oxa-androstanen CH505855A (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CH163071A CH508661A (de) 1967-11-03 1968-10-21 Verfahren zur Herstellung von 4-Oxa-androstanen
CH162871A CH505147A (de) 1967-11-03 1968-10-21 Verfahren zur Herstellung von 4-Oxa-androstanen
CH162971A CH505148A (de) 1967-11-03 1968-10-21 Verfahren zur Herstellung von 4-Oxa-androstanen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68030867A 1967-11-03 1967-11-03

Publications (1)

Publication Number Publication Date
CH505855A true CH505855A (de) 1971-04-15

Family

ID=24730576

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1567068A CH505855A (de) 1967-11-03 1968-10-21 Verfahren zur Herstellung von 4-Oxa-androstanen

Country Status (14)

Country Link
AT (2) AT287932B (fr)
BE (1) BE723189A (fr)
BR (1) BR6803654D0 (fr)
CH (1) CH505855A (fr)
DK (1) DK131576C (fr)
ES (1) ES359842A1 (fr)
FI (1) FI48098C (fr)
FR (2) FR1605466A (fr)
GB (1) GB1247022A (fr)
IE (1) IE33567B1 (fr)
IL (1) IL30879A (fr)
NL (1) NL6815623A (fr)
NO (1) NO132101C (fr)
SE (1) SE352360B (fr)

Also Published As

Publication number Publication date
SE352360B (fr) 1972-12-27
AT287932B (de) 1971-02-10
FR8435M (fr) 1971-07-15
FI48098B (fr) 1974-02-28
IL30879A (en) 1972-11-28
NL6815623A (fr) 1969-05-06
IE33567B1 (en) 1974-08-21
DE1805857A1 (de) 1969-06-26
AT297236B (de) 1972-03-10
NO132101B (fr) 1975-06-09
IE33567L (en) 1969-05-03
NO132101C (fr) 1975-09-17
GB1247022A (en) 1971-09-22
ES359842A1 (es) 1970-06-16
BR6803654D0 (pt) 1973-01-16
IL30879A0 (en) 1968-12-26
DE1805857B2 (de) 1977-06-23
DK131576C (da) 1976-01-05
FI48098C (fi) 1974-06-10
BE723189A (fr) 1969-04-30
DK131576B (da) 1975-08-04
FR1605466A (fr) 1976-05-14

Similar Documents

Publication Publication Date Title
AT281778B (de) Verfahren zur Herstellung von Alk-3-en-1-olen
AT283594B (de) Verfahren zur Herstellung von 7-Halogen-octopyranosiden
AT279602B (de) Verfahren zur Herstellung von Pyrrol-3-yl-ketonen
CH504421A (de) Verfahren zur Herstellung von Bis-thioureido-benzolen
CH499541A (de) Verfahren zur Herstellung von Pyridyl-benzopyranen
CH502292A (de) Verfahren zur Herstellung von o-Isopropylaminobenzophenonen
AT283357B (de) Verfahren zur Herstellung von 2-Aryl-v-triazolen
CH502993A (de) Verfahren zur Herstellung von Ketonitrilen
CH483425A (de) Verfahren zur Herstellung von p-Alkoxy-piperidin-amiden
AT278001B (de) Verfahren zur Herstellung von N-Trityl-imidazolen
CH484930A (de) Verfahren zur Herstellung von Aryloxazolen
CH512423A (de) Verfahren zur Herstellung von Naphthylisopropylaminen
AT281420B (de) Verfahren zur Herstellung von α-Triorganosiloxy-ω-hydroxy-diorganopolysiloxanen
CH510024A (de) Verfahren zur Herstellung von O-Acylpyridoxalen
CH497438A (de) Verfahren zur Herstellung von Difluor-s-triazinen
AT280309B (de) Verfahren zur Herstellung von 3-Methansulfonylphenthiazinen
CH498114A (de) Verfahren zur Herstellung von 2-N-substituierten 2-Amino-5-nitropyridinen
AT284140B (de) Verfahren zur Herstellung von Pyrazinamidoguanidinen
CH505784A (de) Verfahren zur Herstellung von 1-Brom-4-acylaminoanthrachinonen
CH510694A (de) Verfahren zur Herstellung von Organofluorsilanen
CH499492A (de) Verfahren zur Herstellung von äthinylsubstituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
CH504394A (de) Verfahren zur Herstellung von 6-Alkyl-citronellolen
CH496000A (de) Verfahren zur Herstellung von Benzimidazol-N-Oxyden
AT290725B (de) Verfahren zur Herstellung von α-Phenoxyalkylpenizillin
CH487176A (de) Verfahren zur Herstellung von N-Acyloxazolidinen

Legal Events

Date Code Title Description
PL Patent ceased